Go to The Journal of Clinical Investigation
  • About
  • Editors
  • Consulting Editors
  • For authors
  • Publication ethics
  • Transfers
  • Advertising
  • Job board
  • Contact
  • Current issue
  • Past issues
  • By specialty
    • COVID-19
    • Cardiology
    • Immunology
    • Metabolism
    • Nephrology
    • Oncology
    • Pulmonology
    • All ...
  • Videos
  • Collections
    • Resource and Technical Advances
    • Clinical Medicine
    • Reviews
    • Editorials
    • Perspectives
    • Top read articles
  • JCI This Month
    • Current issue
    • Past issues

  • Current issue
  • Past issues
  • Specialties
  • In-Press Preview
  • Editorials
  • Viewpoint
  • Top read articles
  • About
  • Editors
  • Consulting Editors
  • For authors
  • Publication ethics
  • Transfers
  • Advertising
  • Job board
  • Contact
Treg suppression of immunity within inflamed allogeneic grafts
Hehua Dai, … , Simon C. Watkins, Geoffrey Camirand
Hehua Dai, … , Simon C. Watkins, Geoffrey Camirand
Published July 26, 2022
Citation Information: JCI Insight. 2022;7(16):e160579. https://doi.org/10.1172/jci.insight.160579.
View: Text | PDF
Research Article Immunology Transplantation

Treg suppression of immunity within inflamed allogeneic grafts

  • Text
  • PDF
Abstract

CD4+Foxp3+ regulatory T cells (Tregs) restrain inflammation and immunity. However, the mechanisms underlying Treg suppressor function in inflamed nonlymphoid tissues remain largely unexplored. Here, we restricted immune responses to nonlymphoid tissues and used intravital microscopy to visualize Treg suppression of rejection by effector T cells (Teffs) within inflamed allogeneic islet transplants. Despite their elevated motility, Tregs preferentially contacted antigen-presenting cells (APCs) over Teffs. Interestingly, Tregs specifically targeted APCs that were extensively and simultaneously contacted by Teffs. In turn, Tregs decreased MHC-II expression on APCs and hindered Teff function. Last, we demonstrate that Treg suppressive function within inflamed allografts required ectonucleotidase CD73 activity, which generated the antiinflammatory adenosine. Consequently, CD73–/– Tregs exhibited fewer contacts with APCs within inflamed allografts compared with WT Tregs, but not in spleen. Overall, our findings demonstrate that Tregs suppress immunity within inflamed grafts through CD73 activity and suggest that Treg-APC direct contacts are central to this process.

Authors

Hehua Dai, Andressa Pena, Lynne Bauer, Amanda Williams, Simon C. Watkins, Geoffrey Camirand

×

Figure 2

Both Teffs and Tregs are found in APC-rich areas surrounding transplanted islets.

Options: View larger image (or click on image) Download as PowerPoint
Both Teffs and Tregs are found in APC-rich areas surrounding transplante...
(A and B) Representative 3D-rendered IVM-stitched images of islet allografts and immune cells in mice lacking SLOs (as in Figure 1A) that received Teffs alone or Teffs + Tregs 4 days after cell transfer. Islet surfaces were generated on fluorescently labeled transplanted islets (second column), which distinguishes between intra-islet and peri-islet cellular infiltrates (third and fourth columns, respectively). White squares demonstrate magnified areas shown at the bottom of each panel. Scale bar: 200 μm (top) and 50 μm (bottom). (C) Tregs rapidly protected transplanted islets from rejection by Teffs. Violin plot of individual islet size on day 4 measured from images as in A and B. From measurements of 770–860 individual islets per group (4 mice per group). Mann-Whitney test used. Horizontal bars show median. (D) Fraction of cells within each subset that infiltrated within islets (intra-islet) from images, as in A and B. (E and F) Intra-islet and peri-islet density of CD11c+ cells and T cells from images, as in A and B. (G) Fraction of Tregs in the total T cell infiltrate from images, as in B. Each square in D–G represents data from 1 mouse, and horizontal bars show median. Kruskal-Wallis with Dunn’s multiple comparison tests used in D–G. *P < 0.05.

Copyright © 2023 American Society for Clinical Investigation
ISSN 2379-3708

Sign up for email alerts